These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 25907990)

  • 21. Seeded fibrillation as molecular basis of the species barrier in human prion diseases.
    Luers L; Bannach O; Stöhr J; Wördehoff MM; Wolff M; Nagel-Steger L; Riesner D; Willbold D; Birkmann E
    PLoS One; 2013; 8(8):e72623. PubMed ID: 23977331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comments on present-day spread and epidemiology of BSE and prion diseases].
    Bodemer W; Kaup FJ
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning and sequence analysis of prion protein gene in Xiji donkey in China.
    Zhang Z; Wang R; Xu L; Yuan F; Zhou X; Yang L; Yin X; Xu B; Zhao D
    Gene; 2013 Oct; 529(2):345-50. PubMed ID: 23954254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PrP genetics in ruminant transmissible spongiform encephalopathies.
    Goldmann W
    Vet Res; 2008; 39(4):30. PubMed ID: 18284908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scrapie, CWD, and Transmissible Mink Encephalopathy.
    Mathiason CK
    Prog Mol Biol Transl Sci; 2017; 150():267-292. PubMed ID: 28838664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion protein and the molecular features of transmissible spongiform encephalopathy agents.
    Silveira JR; Caughey B; Baron GS
    Curr Top Microbiol Immunol; 2004; 284():1-50. PubMed ID: 15148986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines for prion diseases: a realistic goal?
    Napper S; Schatzl HM
    Cell Tissue Res; 2023 Apr; 392(1):367-392. PubMed ID: 36764940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complex proteinopathies and neurodegeneration: insights from the study of transmissible spongiform encephalopathies.
    Piccardo P; Asher DM
    Arq Neuropsiquiatr; 2018 Oct; 76(10):705-712. PubMed ID: 30427511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion disease: a tale of folds and strains.
    Kretzschmar H; Tatzelt J
    Brain Pathol; 2013 May; 23(3):321-32. PubMed ID: 23587138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission and Replication of Prions.
    Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
    Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
    Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prions and the potential transmissibility of protein misfolding diseases.
    Kraus A; Groveman BR; Caughey B
    Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosemiotics comprehension of PrP code and prion disease.
    Coca JR; Eraña H; Castilla J
    Biosystems; 2021 Dec; 210():104542. PubMed ID: 34517077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.
    Privat N; Levavasseur E; Yildirim S; Hannaoui S; Brandel JP; Laplanche JL; Béringue V; Seilhean D; Haïk S
    J Biol Chem; 2017 Oct; 292(40):16688-16696. PubMed ID: 28821618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.
    Thellung S; Corsaro A; Dellacasagrande I; Nizzari M; Zambito M; Florio T
    Front Neurosci; 2022; 16():966019. PubMed ID: 36148145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.